详情页

资源类型：

文章类型：

作者：

Xu, Jianming[1,2,3,4,6,7,8,9,10,11,12,13] * ; Xiong, Jianping[1,2,3,4,6,7,8,9,10,11,12,13] ; Gu, Shanzhi[1,2,3,4,6,7,8,9,10,11,12,13] ; Niu, Zuoxing[1,2,3,4,6,7,8,9,10,11,12,13] ; Yin, Fei[5]

; Sun, Beicheng[1,2,3,4,6,7,8,9,10,11,12,13] ; Zhang, Lan[5]

; Zhou, Fuxiang[1,2,3,4,6,7,8,9,10,11,12,13] ; Hao, Chunyi[1,2,3,4,6,7,8,9,10,11,12,13] ; Pan, Yueyin[1,2,3,4,6,7,8,9,10,11,12,13] ; Qiu, Wensheng[1,2,3,4,6,7,8,9,10,11,12,13] ; Gao, Yi[1,2,3,4,6,7,8,9,10,11,12,13] ; Ren, Yongxin[1,2,3,4,6,7,8,9,10,11,12,13] ; Fan, Songhua[1,2,3,4,6,7,8,9,10,11,12,13] ; Shi, Michael[1,2,3,4,6,7,8,9,10,11,12,13] ; Su, Weiguo[1,2,3,4,6,7,8,9,10,11,12,13] ;

机构： [1]Department of Medical Oncology,The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China [2]Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China [3]Hunan Cancer Hospital, Changsha, China [4]Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan, China [5]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [6]The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China [7]Zhongshan Hospital, Fudan University, Shanghai, China [8]Zhongnan Hospital, Wuhan University, Wuhan, China [9]Beijing Cancer Hospital and Institute, Beijing, China [10]Anhui Provincial Hospital, Hefei, China [11]Department of Medical Oncology, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China [12]Zhujiang Hospital of Southern Medical University, Guangzhou, China [13]HUTCHMED Limited, Shanghai, China

出处：

ISSN：

基金：

语种：

WOS：

中科院分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Medical Oncology,The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China [2]Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China [3]Hunan Cancer Hospital, Changsha, China [4]Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan, China [6]The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China [7]Zhongshan Hospital, Fudan University, Shanghai, China [8]Zhongnan Hospital, Wuhan University, Wuhan, China [9]Beijing Cancer Hospital and Institute, Beijing, China [10]Anhui Provincial Hospital, Hefei, China [11]Department of Medical Oncology, the Affiliated Hospital of Medical College Qingdao University, Qingdao, China [12]Zhujiang Hospital of Southern Medical University, Guangzhou, China [13]HUTCHMED Limited, Shanghai, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A phase 2 study of HMPL-453, a selective FGFR tyrosine kinase inhibitor (TKI), in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions

文献详情